LN-229 In Vitro Protein Expression Analysis Assay (Immunoassays)

This assay is to provide LN-229-based In Vitro Protein Expression Analysis Assay (Immunoassays) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

LN-229

Human

The LN-229 cell line was established in 1979 from cells taken from a patient with right frontal parieto-occipital glioblastoma [PubMed. 10416987].

Glioblastoma

Oncology

In Vitro Protein Expression Analysis Assay (Immunoassays)

LN-229-cell based In Vitro Protein Expression Analysis Assay (Immunoassays)

For protein expression, western blotting and immunoassays have provided high-quality quantitative results. 2D gel electrophoresis

Gene and Protein Expression Assays

Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.